Skip to main content
  • Research article
  • Open access
  • Published:

Can cognitive insight predict symptom remission in a first episode psychosis cohort?



The outcome of first episode psychosis (FEP) is highly variable and difficult to predict. Cognitive insight measured at illness onset has previously been found to predict psychopathology 12-months later. The aims of this study were to examine whether the prospective relationship between cognitive insight and symptom severity is evident at four-years following FEP and to examine some psychological correlates of cognitive insight.


FEP participants (n = 90) completed the Beck Cognitive Insight Scale (BCIS) at illness onset, and associations between BCIS scores with symptom severity outcomes (4-years after FEP) were assessed. The BCIS scales (self-reflectiveness and self-certainty) were examined as a composite score, and individually compared to other cognitive measures (IQ and jumping to conclusions (JTC) bias).


Regression analyses revealed that the cognitive insight composite did not predict 4-year symptom remission in this study while the self-reflection subscale of the BCIS predicted severity of symptoms at 4-years. Self-certainty items of the BCIS were not associated with symptom severity. Significant correlations between the JTC bias, self-certainty and IQ were found, but self-reflection did not correlate with these other cognitive measures.


Self-reflective capacity is a more relevant and independent cognitive construct than self-certainty for predicting prospective symptom severity in psychosis. Improving self-reflection may be a useful target for early intervention research.

Peer Review reports


The study of higher-order thinking in psychosis populations has been examined using various cognitive constructs. Self-reflective capacity is a meta-cognitive construct defined as the ability to be accurately introspective, and recognise one’s own subjective fallibility [1]. It has been suggested that impaired self-reflection may lead to poor sensory and narrative integration of experience, increasing the risk of psychiatric symptoms [2]. A different but related construct relevant to psychosis research is ‘over-confidence in judgement’, which is thought to manifest behaviourally in reasoning biases such as an early acceptance of incorrect ideas and failure to consider alternatives, and is often found associated with delusional beliefs [35]. Beck and colleagues suggest that self-reflection and confidence in judgement are related though psychometrically distinct concepts, such that a high level of self-certainty might diminish one’s ability or willingness to be introspective [6]. Likewise a sound self-reflective capacity may enable one to redress reasoning biases [6].

The Beck Cognitive Insight Scale (BCIS) [7] examines these two theoretically driven and empirically derived factors: self-certainty, which assesses over-confidence and certainty about being right (e.g. ‘I know better than anyone else what my problems are’), and self-reflectiveness, which assesses willingness to accept fallibility and external feedback, as well as recognising dysfunctional reasoning style (e.g. ‘Some of the ideas I was certain were true turned out to be false’). A composite index can be calculated by subtracting self-certainty from self-reflective scores. Thus high self-reflectiveness and low self-certainty is the formula for good ‘cognitive insight’ [7].

It is proposed in this study, that limited cognitive insight increases one’s risk for experiencing enduring psychotic symptoms over time. Earlier analyses from our research group found that cognitive insight at first-episode psychosis (FEP) is a predictor of overall symptom severity at 12-month follow-up [8]. This finding supports other research which found that cognitive insight is cross-sectionally associated with symptom severity across a range of positive symptoms in psychosis [912]. Until now, the question of whether cognitive insight prospectively predicts symptom outcome beyond 12 months has not been examined.

Understanding the individual BCIS scales within a broader neuro-cognitive framework is also important, and the question of how the individual subscales underlying cognitive insight (self-reflection and self-certainty) operate in psychosis populations still requires scrutiny. While the general consensus is that individuals with psychosis show lower-levels of self-reflection and greater-levels of self-certainty [9, 11, 13, 14] there are studies that report contradictory findings, with some failing to show a significant difference on BCIS subscale scores between people with schizophrenia and healthy controls [15, 16]. Furthermore, Köther et al. [17] demonstrated that self-certainty ratings were actually lower for people with schizophrenia. Elucidating the patterns of association that the BCIS scales have with other cognitive variables might help to explain how cognitive insight is relevant to clinical outcome in psychosis.

While our research group previously found cognitive insight to be distinct in its predictive value from other neuropsychological variables such as executive function, IQ and clinical insight (i.e. one’s awareness of their own psychosis) [18, 19] we did not explore how the BCIS measure relates to other ‘reasoning bias’ type cognitive constructs which are often examined in psychosis research. One such construct is the ‘jumping to conclusions (JTC)’ data-gathering bias [20]. Whilst the relationship between JTC and psychosis is well-established [4, 21, 22], it is still unclear whether JTC behaviour is an accurate measure of ‘overconfidence in judgement’ or measures nothing more than hasty decision making [23]. For this reason, understanding how this data gathering bias correlates with a direct measure of over-confidence (i.e. BCIS self-certainty) is of theoretical interest and may help broaden our knowledge of how self-certainty operates in FEP. It is also important to consider IQ when studying the correlates of these higher-order constructs given the relevance of neuropsychological aspects of cognition to prognosis in psychosis [24, 25].

In light of the current gaps in the literature as described, the aim of the current study was to examine whether cognitive insight can predict four year symptom severity in an FEP sample previously described [8] and explore how the underlying components of cognitive insight (self-certainty and self-reflection) are associated with other cognitive factors (IQ and JTC).



First episode psychosis patients (n = 111) were recruited as part of the National Institute of Health Research (NIHR) and Biomedical Research Centre (BRC), Genetics and Psychosis study. Selection criteria required participants to be aged 18–65 years, who met DSM-IV criteria for psychosis, and presented to the selected boroughs in South London adult mental health services (identified through examination of the clinical notes of new psychiatric admissions and consultation with clinical teams). Further inclusion criteria were applied: contact with psychiatric services for psychosis ≤6 months; fluent English speaker; psychosis identified as having a non-organic cause (e.g. differential diagnoses such as medically induced psychosis i.e. deliriums, a history of head injury or neurological condition were exclusions). All those patients identified as eligible, were approached as soon as possible and invited to take part in the study. Research diagnoses were provided by qualified psychiatrists subject to inter-rater reliability checks (Intra class correlation = .97) using the Operational Criteria for studies of psychotic illness (OPCRIT) [26].


Demographic data were collected from self-report, supplemented by clinical records, at study entry.

Cognitive measures

Cognitive insight was measured using the Beck Cognitive Insight Scale: BCIS [7]. This is a 15 item self-report scale, with items rated from ‘do not agree at all’ to ‘agree completely’. There are two subscales which measure participant endorsement of: ‘self-reflectiveness’ (nine items, range 9 to 63), and ‘self-certainty’ (six items, range 6 to 42). A cognitive insight score was derived by deducting the BCIS self-certainty scale item total from the BCIS self-reflective scale item total. Consistent with our previous research [8], each BCIS item was rated on 7- point scale instead of the original 4-point scale, to increase the precision of this measure [27]. Confirmatory factor analysis conducted in this study sample suggests that factor loadings for both constructs were equivalent to the original item loadings [7], and the two factor model reached statistical significance (t-ratio >1.96) [28]. Cronbach’s α for the self-certainty and self-reflective scale in this study was 0.76 and 0.71 respectively, higher than the consistencies achieved in the original BCIS publication paper [7].

The ‘Jumping to Conclusions’ or JTC bias, was measured by the behavioural response to a probabilistic reasoning paradigm called ‘The Beads Task’ [29]; in the version used for this study, participants were shown two jars that contain coloured beads (orange or black). Each jar contained beads in a different proportion, e.g. one jar contains 85 black and 15 orange beads, and the other jar contains the reverse proportion. Participants were informed of and shown the coloured bead proportions, before the containers were removed from view. Participants were then told that each jar (either the jar containing mainly orange beads or that containing mainly black beads) has the same probability of being chosen by the researcher (50:50) and that beads will be extracted from the selected jar and shown to participants one at a time. It was the participant’s task to decide from which of the two jars the beads were being taken; the mainly orange or the mainly black jar. They were told that they should only decide when they are certain. We adopted the ‘two or less draw to decision threshold’ measure to identify JTC bias, as this measure has been shown to be most reliably associated with delusions [30, 31]. A tendency to ‘Jump to Conclusions’ was operationally defined as the respondent making a decision after two beads or fewer, as this threshold has been used in other FEP studies [32, 33]. To estimate IQ, a short version of the Wechsler Adult Intelligence Scale -Third Edition: WAIS III [34] was administered and included the following subtests: Information, Digit Span, Block Design, Matrix Reasoning and Digit Symbol Coding. These particular subtests were chosen because they index a wide range of cognitive abilities, including all relevant IQ domains. These scores were averaged within their domain and multiplied by the total number of WAIS III subtests in each domain to approximate an individual IQ score; using short-forms of WAIS is common in psychosis research to estimate full scale IQ [3538].


The Positive and Negative Syndrome Scale (PANSS) [39] was used to rate symptoms at study entry. Only the positive and negative scales were examined in this study. Each item is scored on a scale of 1 to 7: absent, minimal, mild, moderate, moderate severe, severe and extreme. A score of 4 (moderate) or higher indicates the presence of clinical psychopathology. Item ratings were completed through interview with participants and by collecting collateral information from healthcare workers based on 7 days prior to assessment. Inter-rater agreement coefficients for rating pairs (n = 22) were calculated using a Spearman-Brown formula (agreement amongst multiple observers corrected for number of observers). Mean level of agreement was r = 0.814, which is above conventionally accepted thresholds for adequate inter-rater agreement [40].

The Global Assessment of Functioning (GAF) [41] was used to measure overall illness severity at study entry and at follow-up. The GAF is a widely used observer-rated instrument to determine clinical and functional status on a scale from 1 to 100. We measured symptom experience (GAF-S) separately to functional disability (GAF-F). Making this distinction between these two recovery types on the GAF has been shown to improve the psychometric properties of this measure [42]. Information for GAF-S ratings were derived from “any source, such as direct interview of the patient, a reliable informant, or a case record” [41] (p767). In this study, clinical notes were used or when possible, GAF-S was rated following face to face interview. Raters were subject to inter-rater reliability checks, achieving excellent intra-class correlations when rating GAF-S from clinical records (ICC > 0.90) [43]. Further, GAF-S scores collected from clinical records compared to GAF-S scored via face to face interview showed high comparability (ICC = .81) [43].

Design and procedure

The study used a within subject longitudinal design to analyse relationships between cognitive insight collected at the first onset of psychosis and GAF-S collected at 4-year follow-up. The initial sample of interest (n = 111) consisted only of participants who completed all cognitive measures of interest to this study at baseline (87% of total sample evaluated at O’Connor et al. 12 month follow-up study [8]). Baseline variables (GAF-S, JTC, IQ, PANSS, demographic factors and diagnoses) were analysed as possible covariates, and to characterise the patient sample. Participants completed measures at follow-up with an attrition rate of 18.9% (see Fig. 1 for details). The majority of this sample (95%) formed part of the 12 month follow-up in our previous study [8]. The average follow-up time was 49 months, or just over four years post FEP (sd = 11.5, range 27–86 months).

Fig. 1
figure 1

Flowchart indicating follow-up methodology and attrition rate

Data analysis

Hierarchical multiple regression was conducted with GAF symptoms at four-years as the dependent variable and cognitive insight (BCIS composite score) as the predictor variable. Analyses of Pearson’s and point bi-serial correlations were conducted to examine relationships between covariates and the dependent variable (GAF-S at 4 year follow-up); covariates which correlated highly with the outcome measure (p < .01 and of greater magnitude than r = .25) were entered into subsequent regression modelling [44], before cognitive insight was entered at step 2. Correlation analyses enabled the investigation of relationships between the BCIS scales and other cognitive variables (IQ and JTC bias).


Descriptive baseline data

Table 1 describes the demographic, clinical and cognitive characteristics of this sample that completed follow-up at four-years after FEP (n = 90). Participants were classified into eight different diagnostic categories according to the DSM IV. The most common diagnosis was schizophreniform disorder (28.8%) and the majority of participants (57.7%) were classified as having a non-affective psychosis. In terms of symptom severity, the mean PANSS positive and negative symptom subscale scores suggest that the average participant was ‘mildly unwell’ at baseline assessment. In terms of cognitive descriptive data, other than those reported in Table 1, the self-reflective scale (SR) and the self-certainty scale (SC) scales were negatively correlated (r = −.253). The mean IQ score was in the low-average range commensurate with previous FEP findings [45]. Nearly half the sample (45%) showed a JTC bias according to a <2 beads threshold, which is also consistent with previous FEP findings [32].

Table 1 Sample Characteristics (N = 90)

Follow-up data

There were no significant differences between those who were traceable for 4-year follow-up assessment (n = 90) versus those who had become untraceable at follow-up (n = 21), with the exception of baseline GAF-S scores, in that those who were untraceable at follow-up had significantly more psychopathology at baseline: t (109) = −2.341, p = 0.012. Compared to baseline, GAF symptom severity was significantly lower at 4-year follow-up (t (87) = −4.816, p < 0.001 respectively). A 4-years, the cohort mean GAF symptom score was above remission thresholds for FEP (>59) [46].

Main analysis

Correlation analysis was conducted to determine which baseline predictors should be entered into predictor models. Only variables that correlated significantly with GAF symptom outcome at 4 year follow-up as outlined above were entered into subsequent regression models. The GAF Time-0 symptom measure did not correlate with GAF symptoms as 4 year follow-up. GAF symptom scores at four-year follow-up were significantly correlated with baseline negative symptoms (r = −.320) and diagnosis (rpb = .294) such that less severe negative symptoms and an affective diagnosis at FEP onset was associated with decreased psychopathology at 4-year follow-up. Therefore these variables were entered into the hierarchical regression at step 1, and cognitive insight was entered at step 2. Overall, the model was significant and negative symptoms, diagnosis and cognitive insight accounted for approximately 15% of variance in symptom outcome [F(3,79) = 4.797, p = 0.002]. However, cognitive insight uniquely accounted for just 0.6% of variance in symptom outcome, which was not a significant individual contribution to the model [F (3, 79) = .585 p = 0.447 R2 = .148, adjusted R2 = .115)].

Post hoc analysis of the BCIS scales individually revealed that self-reflectiveness was significantly correlated with symptom outcome at 4-years such that greater ability to self-reflect was associated with less severe symptoms prospectively (r = .25), although not cross-sectionally, at baseline (r = −.09). Conversely, self-certainty did not correlate with symptom outcome at 4-years (r = .021) although its relationship with symptoms cross-sectionally at baseline was nearing significance (r = −.18, p = 0.08).

The two BCIS subscales were entered separately in the regression model to identify unique contributions of self-reflectivity and self-certainty on symptom outcome at 4 years. Overall, the model was significant (F (4, 78) =5.258, p = 0.046), and by entering the BCIS subscales separately, an increase in 6.5% of variance in symptom outcome was explained (adjusted R2 = .172). Higher scores on the self-reflectiveness sub-scale predicted significantly higher GAF-S scores (i.e. less severe psychopathology) at Time 2 follow-up (t (78) =2.324, p = .023). The self-certainty sub-scale did not contribute significantly to the variance (t (78) =1.57, p = .199). Table 2 reports the unique contribution of each variable entered into the regression model.

Table 2 Hierarchical regression to predict symptom severity at four-year follow up

In summary, analyses of the BCIS scales individually revealed that self-reflectiveness was significantly correlated with symptom outcome prospectively. The self-certainty subscale was not associated with later symptom outcome, although its relationship with symptoms cross-sectionally at baseline approached significance (higher self-certainty related to greater concurrent symptom severity).

Finally, in terms of the BCIS subscales’ relationship to other cognitive variables, the self-certainty items had a significant, though weak association with the JTC bias (r = −.258) and IQ (r = −.313) such that higher self-certainty was associated with a tendency to jump to conclusions, and lower IQ. Neither the JTC measure, nor IQ was significantly correlated with the BCIS self-reflective scale (r = .029, and r = .033 respectively).


Cognitive insight (as measured by the BCIS composite score) did not predict symptom severity at four years post FEP, but the self-reflective sub-scale did. Participants who endorsed highly self-reflective behaviour, i.e. greater agreement with scale items such as, “some of my experiences that have seemed very real may have been due to my imagination”, had fewer and less severe psychopathological symptoms at four-years after psychosis onset, compared to those individuals who did not endorse these items. Direct and indirect measures relating to confidence in judgement (BCIS self-certainty scale and JTC bias) did not contribute to symptom outcome, though these factors correlated significantly with each other, and IQ.

These findings contradict some previous studies, which found that the correlation between the combined cognitive insight construct and symptom outcome is stronger than that between individual subscales and symptom outcome [8, 9, 47]. However, previous studies have only examined the cross-sectional and short-term prospective relationships between the cognitive insight and symptom outcome and this is the first study to examine these relationships in the medium-term (four years) after FEP. This suggests a complex longitudinal relationship between the BCIS and clinical status, such that aspects of the BCIS measuring meta-cognitive thinking (self-reflective items) have a more prospective relationship to symptom experience, whereas those items indexing ‘confidence in judgement’ (self-certainty items) tend to correlate more highly to concurrent symptoms.

The converging associations between JTC, self-certainty and IQ support a growing body of evidence that reasoning processes are underpinned by general intellectual functions [48, 49]. For instance, the literature suggests that schizophrenia and delusional prone participants tend to show ‘overconfident judgement’ in relation to their own objective ‘errors’, but they do not show the same level of conviction for their correct responses on tasks (see Balzan et al. for a review [23]). The association found between the JTC and BCIS self-certainty scale is also relevant to contention in the field as to whether the JTC beads task is measuring more than hasty decision making [23]. Our findings tentatively support the notion that the JTC Beads task is perhaps tapping into the same ‘confidence in judgement’ factor as the BCIS self-certainty scale.

Our, results also suggest that self-reflective aspects of thinking are unrelated to other measured cognitive constructs (JTC or IQ) consistent with reports from recent meta-analyses, that the BCIS self-reflective scale had fewer neuropsychological correlates than the self-certainty scale [49]. By virtue of its lack of correlation with neuropsychological function, poor self-reflective capacity may be more amenable to change through psychological support. Indeed, psycho-social interventions have been shown to change participant endorsement of the self-reflective scale items, but not self-certainty items [9, 50, 51].

It would be valuable to know whether self-reflection can predict the severity of some specific psychotic symptoms more than others (i.e. hallucinations vs. delusions). Understanding this would be particularly informative, given recent calls for the development of symptom-specific interventions in psychosis [52]. Indeed one previous CBT for psychosis intervention found that higher endorsement of the BCIS self-reflection items was associated with clinically significant delusional improvements, but was not linked to changes in hallucinations [47].

Our results should be considered in view of the limitations of the study. Follow-up assessment occurred when participants were willing to be interviewed, or when clinical records were available, and so did not always occur strictly within 4-year window. In terms of generalisability, those participants missing at follow-up did have significantly more severe psychopathology at baseline on the GAF symptom measure than those participants retained at follow-up. This may have caused some sample bias, but its effect on the strength of association with BCIS measures is unclear. Evidence suggests that acuteness of psychosis at illness-onset predicts better symptom outcomes [53], which means this study might be underestimating the rates of positive recovery outcomes [54]. Nevertheless, it seems unlikely that this identified difference between those lost at follow-up and the follow-up sample, impacted upon the main findings, given that the baseline GAF symptom severity was not a confounding variable in the regression model. Finally, it is unfortunate that data on BCIS and JTC were not collected at follow-up as it would have been useful to more directly measure the stability of these constructs over time.


Through employing a longitudinal design, we present evidence that subjective self-reflection has an important role in predicting symptom remission in early psychosis. These findings reveal a potentially important target for psychological intervention.


  1. Koren D, Seidman LJ, Goldsmith M, Harvey PD. Real-world cognitive and metacognitive dysfunction in schizophrenia: a new approach for measuring (and remediating) more “right stuff”. Schizophr Bull. 2006;32:310–26.

    Article  PubMed  PubMed Central  Google Scholar 

  2. David A, Bedford N, Wiffen B, Gilleen J. Failures of metacognition and lack of insight in neuropsychiatric disorders. Philos Trans R Soc B. 2012;367:1379–90.

    Article  Google Scholar 

  3. Colbert SM, Peters ER, Garety PA. Delusions and belief flexibility in psychosis. Psychol Psychother Theory Res Pract. 2010;83:45–57.

    Article  CAS  Google Scholar 

  4. Moritz S, Woodward TS. Jumping to conclusions in delusional and non-delusional schizophrenic patients. Br J Clin Psychol. 2005;44:193–207.

    Article  PubMed  Google Scholar 

  5. White LO, Mansell W. Failing to ponder? Delusion-prone individuals rush to conclusions. Clin Psychol Psychother. 2009;16:111–24.

    Article  PubMed  Google Scholar 

  6. Beck AT, Warman DM. Cognitive insight: theory and assessment. In: Amador XF, David AS, editors. Insight and psychosis: awareness of illness in schizophrenia and related disorders. 2nd ed. New York: Oxford University Press; 2004. p. 79–87.

    Chapter  Google Scholar 

  7. Beck A, Baruch E, Balter JM, Steer RA, Warman DM. A new instrument for measuring insight: the Beck Cognitive Insight Scale. Schizophr Res. 2004;68:319–29.

    Article  PubMed  Google Scholar 

  8. O’Connor JA, Wiffen B, DiForti M, Ferraro L, Joseph C, Kolliakou A, David AS, et al. Neuropsychological, clinical and cognitive insight predictors of outcome in a first episode psychosis study. Schizophr Res. 2013;149:70–6.

    Article  PubMed  Google Scholar 

  9. Bora E, Erkan A, Kayahan B, Veznedaroglu. Cognitive insight and acute psychosis in schizophrenia. Psychiatry Clin Neurosci. 2007;61:634–9.

    Article  PubMed  Google Scholar 

  10. Buchy L, Malla A, Joober R, Lepage M. Delusions are associated with low self-reflectiveness in first-episode psychosis. Schizophr Res. 2009;112:187–91.

    Article  CAS  PubMed  Google Scholar 

  11. Engh JA, Friis S, Birkenaes AB, Birkenaes AB, Jonsdottir H, Klungsøyr O, Ringen PA. Delusions Are associated with poor cognitive insight in schizophrenia. Schizophr Bull. 2010;36:830–5.

    Article  PubMed  Google Scholar 

  12. Pedrelli P, McQuaid JR, Granholm E, Patterson TL, McClure F, Beck AT, et al. Measuring Cognitive Insight in middle-aged and older participants with psychotic disorders. Schizophr Res. 2004;71(2–3):297–305.

    Article  PubMed  Google Scholar 

  13. Bruno N, Sachs N, Demily C, Franck N, Pacherie E. Delusions and metacognition in patients with schizophrenia. Cogn Neuropsychiatry. 2011;17:1–18.10.

    Article  PubMed  Google Scholar 

  14. Lysaker PH, Olesek KL, Warman DM, Martin JM, Salzman AK, Nicolò G, … Dimaggio, G. Metacognition in schizophrenia: Correlates and stability of deficits in theory of mind and self-reflectivity. Psychiatr Res. 2011;190:18–22.

  15. Engh JA, Friis S, Birkenaes AB, Jónsdóttir H, Ringen PA, Ruud T, Sundet KS, Opjordsmoen S, Andreassen OA. Measuring cognitive insight in schizophrenia and bipolar disorder: a comparative study. BMC Psychiatry. 2007;11:1–71.

    Google Scholar 

  16. Kao YC, Liu YP. The Beck Cognitive Insight Scale (BCIS): translation and validation of the Taiwanese version. BMC Psychiatry. 2010;1:10–27.

    Google Scholar 

  17. Köther U, Veckenstedt R, Vitzthum F, Roesch-Ely D, Pfueller U, Scheu F, Moritz S. “Don’t give me that look”—Overconfidence in false mental state perception in schizophrenia. Psychiatry Res. 2012;196(1):1–8.

    Article  PubMed  Google Scholar 

  18. David A. Insight and psychosis. Br J Psychiatry. 1990;156:798–808.

    Article  CAS  PubMed  Google Scholar 

  19. David A. The clinical importance of insight: an overview. In: Amador XF, David A, editors. Insight and psychosis: awareness of illness in Schizophrenia and related disorders. 2nd ed. Oxford: Oxford University Press; 2004. p. 359–92.

    Chapter  Google Scholar 

  20. Garety P, Freeman D. The past and future of delusions research: from the inexplicable to the treatable. Br J Psychiatry. 2013;203:327–33.

    Article  CAS  PubMed  Google Scholar 

  21. Bentham AMP, McKay A, Quemada I, Clare L, Eastwood N, McKenna P. Delusions in schizophrenia: a phenomenological and psychological exploration. Cogn Neuropsychiatry. 1996;1(4):289–304.

    Article  CAS  PubMed  Google Scholar 

  22. Menon M, Pomarol Clotet E, McKenna PJ, McCarthy R. A Probabilistic reasoning in schizophrenia: a comparison of the performance of deluded and non-deluded schizophrenic participants and exploration of possible cognitive underpinnings. Cogn Neuropsychiatry. 2006;11(6):521–36.

    Article  PubMed  Google Scholar 

  23. Balzan RP. Overconfidence in psychosis: the foundation of delusional conviction? Cogent Psychol. 2016;3(1):1135855.

    Article  Google Scholar 

  24. David AS, Zammit S, Lewis G, Dalman C, Allebeck P. Impairments in cognition across the spectrum of psychiatric disorders. Evidence from a Swedish conscript cohort. Schizophr Bull. 2008;34:1035–41.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res. 2004;72:41–51.

    Article  PubMed  Google Scholar 

  26. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT system. Arch Gen Psychiatry. 1991;48:764–70.

    Article  CAS  PubMed  Google Scholar 

  27. Preston CC, Colman A. Optimal number of response categories in rating scales: reliability, validity, discriminating power, and respondent preferences. Acta Psychol. 2000;104:1–15.

    Article  CAS  Google Scholar 

  28. Wang J, Wang X. Structural equation modelling: applications using Mplus. Chichester: Wiley; 2012.

    Book  Google Scholar 

  29. Huq S, Garety P, Hemsley D. Probabilistic judgements in deluded and non-deluded subjects. Q J Exp Psychol. 1988;40:801–12.

    Article  CAS  Google Scholar 

  30. Fine C, Gardner M, Craigie J, Gold I. Hopping, skipping or jumping to conclusions? Clarifying the role of the JTC bias in delusions. Cogn Neuropsychiatry. 2007;12(1):46–77.

    Article  PubMed  Google Scholar 

  31. Garety P, Freeman D, Jolley S, Dunn G, Bebbington P, Fowler G, et al. Reasoning, emotions, and delusional conviction in psychosis. J Abnorm Psychol. 2005;114(3):373.

    Article  PubMed  Google Scholar 

  32. Dudley R, Shaftoe D, Cavanagh K, Spencer H, Ormrod J, Turkington D, Freeston M. ‘Jumping to conclusions’ in first‐episode psychosis. Early Interv Psychiatry. 2011;5(1):50–6.

    Article  PubMed  Google Scholar 

  33. Falcone MA, Murray RM, Wiffen BD, O’Connor JA, Russo M, Kolliakou A, Jolley S. Jumping to conclusions, neuropsychological functioning, and delusional beliefs in first episode psychosis. Schizophr Bull. 2014;41(2):411–8.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Wechsler D. WAIS-III: Wechsler adult intelligence scale. San Antonio: Psychological Corporation; 1997.

    Google Scholar 

  35. Missar CD, Gold JM, Goldberg TE. WAIS-R short forms in chronic schizophrenia. Schizophr Res. 1994;12(3):247–50.

    Article  CAS  PubMed  Google Scholar 

  36. Holthausen EA, Wiersma D, Cahn W, Kahn RS, Dingemans PM, Schene AH, van den Bosch RJ. Predictive value of cognition for different domains of outcome in recent-onset schizophrenia. Psychiatry Res. 2007;149(1):71–80.

    Article  PubMed  Google Scholar 

  37. Leeson VC, Barnes TRE, Hutton SB, Ron MA, Joyce EM. IQ as a predictor of functional outcome in schizophrenia: a longitudinal, four year study of first-episode psychosis. Schizophr Res. 2009;107:55–60.

    Article  PubMed  PubMed Central  Google Scholar 

  38. O’Connor JA, Wiffen BD, Reichenberg A, Aas M, Falcone MA, Russo M.... and David AS. Is deterioration of IQ a feature of first episode psychosis and how can we measure it?. Schizophr Res. 2012;137(1):104–9.

  39. Kay SR, Flszbein A, Opfer LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.

    Article  CAS  PubMed  Google Scholar 

  40. Fleiss JL. Design and analysis of clinical experiments. New York: Wiley; 1986.

    Google Scholar 

  41. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry Res. 1976;33:766–71.

    Article  CAS  Google Scholar 

  42. Pedersen G, Hagtvet KA, Karterud S. Generalizability studies of the Global Assessment of Functioning–Split version. Compr Psychiatry. 2007;48(1):88–94.

    Article  PubMed  Google Scholar 

  43. Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess. 1994;6:284.

    Article  Google Scholar 

  44. Cohen J. A power primer. Psychol Bull. 1992;112(1):155–9.

    Article  CAS  PubMed  Google Scholar 

  45. Carlsson R, Nyman H, Ganse G, Cullberg J. Neuropsychological functions predict 1 and 3 year outcome in first episode psychosis. Acta Psychiatr Scand. 2006;113:102–11.

    Article  CAS  PubMed  Google Scholar 

  46. Bertelsen M, Jeppesen P, Petersen L, Thorup A, Øhlenschlæger J, Le Quach P, …and Nordentoft M. Course of illness in a sample of 265 patients with first-episode psychosis--Five-year follow-up of the Danish OPUS trial. Schizophr Res. 2009;107:173–8.

  47. Perivoliotis D, Grant PM, Peters ER, Ison R, Kuipers E, Beck AT. Cognitive Insight predicts favorable outcome in cognitive behavioral therapy for psychosis. Psychosis. 2010;21(1):23–33.

    Article  Google Scholar 

  48. Lincoln TM, Ziegler M, Mehl S, Rief W. The jumping to conclusions bias in delusions: specificity and changeability. J Abnorm Psychol. 2010;119(1):43–50.

    Article  Google Scholar 

  49. Nair A, Palmer EC, Aleman A, David AS. Relationship between cognition, clinical and Cognitive Insight in psychotic disorders: a review and meta-analysis. Schizophr Res. 2014;152(1):191–200.

    Article  PubMed  Google Scholar 

  50. Granholm E, Auslander L, Gottlieb J, McQuaid J, McClure F. Therapeutic factors contributing to change in cognitive-behavioural group therapy for older persons with schizophrenia. J Contemp Psychother. 2006;36:31–41.

    Article  Google Scholar 

  51. Lam KC, Ho CP, Wa JC, Chan SM, Yam KK, Yeung OS, Wong WC, Balzan RP. Metacognitive training (MCT) for schizophrenia improves cognitive insight: a randomized controlled trial in a Chinese sample with schizophrenia spectrum disorders. Behav Res Ther. 2015;31:38–42.

    Article  Google Scholar 

  52. Freeman D, Garety P. Advances in understanding and treating persecutory delusions: a review. Soc Psychiatry Psychiatr Epidemiol. 2014;49:1179–89.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Jablensky A, Sartorius N, Ernberg G, Sartorius N, ErnbergG, Anker M, Korten A, Cooper JE, … and Bertelsen, A. Schizophrenia: manifestations, incidence and course in different cultures A World Health Organization Ten-Country Study. Psychol Med Monogr Suppl. 1992;20:1–97.

  54. Menezes NM, Arenovich T, Zipursky B. A systematic review of longitudinal outcome studies of first-episode psychosis. Psychol Med. 2006;36:1349–62.

    Article  CAS  PubMed  Google Scholar 

Download references


We would firstly like to thank every research participant who generously shared their time, energy and personal experience to make this research possible. We are grateful for the support of all GAP researchers, Principle Investigators and funders for their contribution and support of this study.


We acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health award to South London and Maudsley NHS Foundation Trust (SLaM) and the Institute of Psychiatry, Psychology and Neuroscience at King’s College London. Follow-up data collection was financially supported by a NIHR clinician scientist award to Sagnik Bhattacharyya. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.

Availability of data and materials

The data are part of a continuing follow-up study which is part of a larger cohort supported by the NIHR Biomedical Research Centre, which will include additional psychosocial and biological measures. Once the data collection is complete the data will be made publically available through the BRC. In the meantime we are happy to share the data on which this analysis was based on request from bona fide researchers at no cost.

Authors’ contributions

Authors JO, LE and AD designed the present study using data from the GAP project, and selecting the measures. JO collected, scored and input data, analysed and interpreted the findings and wrote the manuscript. OA, TS AK, AT, BW and MAF made substantial contributions to the acquisition of data, and assisted with analyses. Authors MDF, RM, SB and AD were the principle investigators for the project from which this study was derived; they assisted the interpretation of the findings and approved the final manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Full ethical approval was obtained from the Institute of Psychiatry and South London and Maudsley NHS Foundation Trust Research Ethics Committee (REC NO05/Q0706/158). Patients provided written consent to participate and were made aware that their involvement was voluntary and that they could refuse re-approach or withdraw from the study at any point without indicating reason and without impact on their ongoing clinical care. All study materials used were approved by the ethics committee and right to publish received.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Jennifer A. O’Connor.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

O’Connor, J.A., Ellett, L., Ajnakina, O. et al. Can cognitive insight predict symptom remission in a first episode psychosis cohort?. BMC Psychiatry 17, 54 (2017).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: